NCT04334512View on ClinicalTrials.gov

A Study of Quintuple Therapy to Treat COVID-19 Infection

PHASE2CompletedINTERVENTIONAL
Enrollment

118

Participants

Timeline

Start Date

June 22, 2020

Primary Completion Date

February 27, 2024

Study Completion Date

February 27, 2024

Conditions
COVID-19Corona Virus InfectionCoronavirus-19Sars-CoV2
Interventions
DRUG

Hydroxychloroquine

Treatment with hydroxychloroquine

DRUG

Azithromycin

Treatment with azithromycin

DIETARY_SUPPLEMENT

Vitamin C

Treatment with vitamin C

DIETARY_SUPPLEMENT

Vitamin D

Treatment with vitamin D

DIETARY_SUPPLEMENT

Zinc

Treatment with Zinc

Trial Locations (1)

93003

ProgenaBiome, Ventura

Sponsors

Lead Sponsor

ProgenaBiome
All Listed Sponsors
collaborator

DSCS CRO

INDUSTRY

lead

ProgenaBiome

OTHER

NCT04334512 - A Study of Quintuple Therapy to Treat COVID-19 Infection | Biotech Hunter | Biotech Hunter